When and which patients should receive remdesivir?

Carolina Garcia-Vidal
, Maurizio Sanguinetti

University of Barcelona

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	1918-1920
Number of pages	3
Journal	The Lancet
Volume	399
DOIs	https://doi.org/10.1016/S0140-6736(22)00789-9
Publication status	Published - 2022

Keywords

Resdemevir

Access to Document

10.1016/S0140-6736(22)00789-9

Other files and links

Link to IRIS PubliCatt

Cite this

@article{1aede95681fa4949a5a52477ef45675a,

title = "When and which patients should receive remdesivir?",

keywords = "Resdemevir, Resdemevir",

author = "Carolina Garcia-Vidal and Maurizio Sanguinetti",

year = "2022",

doi = "10.1016/S0140-6736(22)00789-9",

language = "English",

volume = "399",

pages = "1918--1920",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - When and which patients should receive remdesivir?

AU - Garcia-Vidal, Carolina

AU - Sanguinetti, Maurizio

PY - 2022

Y1 - 2022

KW - Resdemevir

KW - Resdemevir

UR - http://hdl.handle.net/10807/231812

U2 - 10.1016/S0140-6736(22)00789-9

DO - 10.1016/S0140-6736(22)00789-9

M3 - Article

SN - 0140-6736

VL - 399

SP - 1918

EP - 1920

JO - The Lancet

JF - The Lancet

ER -